Mr Michael Han > Fangda Partners > Beijing, China > Lawyer Profile

Fangda Partners has a market-leading antitrust and competitions practice, which specialises in merger control, investigations, antitrust litigation, and strategic and operational counselling. Specifically, in light of the amendments to the Anti-Monopoly Law of China in 2022, the firm has been providing counselling to clients on compliance with the amended Anti-Monopoly Law, particularly in implementing and coordinating compliance audits and programs and ensuring the compliance of new business models. Caroline Huang excels in merger filings, administration investigations, and compliance reviews. The well-regarded Michael Han is regularly instructed on a range of high-profile matters including merger control, competition litigation, and strategic and operational counselling.

Fangda Partners offers an extensive life sciences and healthcare focussed team representing an array of medical technology companies and investors, both PRC and multinational. The team is particularly recommended for its expertise in financing and fundraisings. Practice head Josh Shin is expert on regulatory-related issues including R&D, clinical trials, HGRAC regulation and patient centric transformation. Kate Yin is recommended for handling investigations work in the healthcare space, covering anti-bribery, accounting fraud, securities law, conflict of interest, trade secrets and data security. IP expert Fang Qi, antitrust investigations specialist Michael Han and the M&A and foreign investment focussed Diana Li are also central to the team. Henry He, who joined the firm from C-Stone Pharmaceuticals in January 2023, is a further key name.

Fangda Partners is a popular choice for highly complex private equity M&A and commercial transactions for clients in a wide range of industries, including healthcare, financial services, and technology. Norman Zhong splits his time between Shanghai and Hong Kong; he recently advised FFH on its joint acquisition (with Bank of China) of the village bank portfolio from a major PRC bank, and fifteen village banks from China Development Bank. Zhong jointly leads the Shanghai team with Miles Ma, who recently advised Blackstone on its acquisition of Shya Hsin’s cosmetics packaging business. Zhong and Ma are supported by a strong team including Beijing-based Jeffery Ding and Michael Han who also has notable experience in Chinese competition matters relating to M&A and joint ventures.